Is Coya Therapeutics, Inc. (COYA) Outperforming Other Medical Stocks This Year?

Another stock in the Medical sector, Doximity (DOCS) , has outperformed the sector so far this year. The stock's year-to-date return is 6.2%. In Doximity's case, the consensus EPS estimate for the current year increased 13.2% over the past three months. The stock currently has a Zacks Rank #2 (Buy). Looking more specifically, Coya Therapeutics, Inc. belongs to the Medical - Biomedical and Genetics industry, a group that includes 508 individual stocks and currently sits at #76 in the Zacks Industry Rank. Thi ...